Tammenoms Bakker Juliet

Average Profitability
44.34%
Insider Buys Quantity
5
Insider Buys Sum
$16.91M
Insider Sells Quantity
10
Insider Sells Sum
$30.74M

Insider Activity of Tammenoms Bakker Juliet

According to the SEC Form 4 filings, Tammenoms Bakker Juliet, being in a position of

  1. director at RxSight, Inc.,
    оver the last 12 months, has bought 13000 shares for $712,129, and sold 494313 shares for $14.7M,
    over all time since 2021-08-03, has bought 1130500 shares for $16.91M, and sold 1076606 shares for $30.74M.

The largest purchase of all time was on 2021-08-03 and amounted to 637500 shares of RxSight, Inc. for $10.2M.

The largest sale of all time was on 2023-11-15 and amounted to 400000 shares of RxSight, Inc. for $10.88M.

Biography of Tammenoms Bakker Juliet

No biography is available at this moment.

2024-05-17PurchaseRxSight, Inc.
RXST
director
5,000
0.0124%
$61.09$305,457-12.7%
2024-02-14PurchaseRxSight, Inc.
RXST
director
4,000
0.0113%
$51.29$205,153+2.57%
2024-02-12PurchaseRxSight, Inc.
RXST
director
4,000
0.0112%
$50.38$201,520+4.91%
2023-11-29SaleRxSight, Inc.
RXST
director
349,245
0.9733%
$29.77$10.4M+71.64%
2023-11-28SaleRxSight, Inc.
RXST
director
145,068
0.4077%
$29.62$4.3M+72.64%
2023-11-15SaleRxSight, Inc.
RXST
director
400,000
1.1094%
$27.20$10.88M+83.54%
2023-11-14SaleRxSight, Inc.
RXST
director
100,000
0.2808%
$27.13$2.71M+87.68%
2023-09-11SaleRxSight, Inc.
RXST
director
2,950
0.0082%
$30.01$88,525+57.89%
2023-09-08SaleRxSight, Inc.
RXST
director
10,033
0.0294%
$30.25$303,461+63.94%
2023-09-07SaleRxSight, Inc.
RXST
director
19,967
0.0569%
$30.10$600,983+59.79%
2023-08-25SaleRxSight, Inc.
RXST
director
16,208
0.0451%
$29.25$474,129+59.25%
2023-08-18SaleRxSight, Inc.
RXST
director
14,651
0.0418%
$29.07$425,877+55.12%
2023-08-17SaleRxSight, Inc.
RXST
director
18,484
0.0553%
$30.06$555,694+57.15%
2023-02-10PurchaseRxSight, Inc.
RXST
director
480,000
1.4793%
$12.50$6M+110.76%
2021-08-03PurchaseRxSight, Inc.
RXST
director
637,500
3.3303%
$16.00$10.2M-22.08%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.